ABBENANTE, MARIACHIARA
 Distribuzione geografica
Continente #
NA - Nord America 530
EU - Europa 131
AS - Asia 47
AF - Africa 4
SA - Sud America 2
OC - Oceania 1
Totale 715
Nazione #
US - Stati Uniti d'America 526
FR - Francia 35
IT - Italia 29
IE - Irlanda 21
DE - Germania 18
AE - Emirati Arabi Uniti 11
CN - Cina 11
BG - Bulgaria 7
JP - Giappone 7
VN - Vietnam 7
CA - Canada 4
GB - Regno Unito 4
RU - Federazione Russa 4
FI - Finlandia 3
IN - India 3
KR - Corea 3
CH - Svizzera 2
GR - Grecia 2
MA - Marocco 2
TR - Turchia 2
UA - Ucraina 2
ZA - Sudafrica 2
AU - Australia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
ES - Italia 1
HK - Hong Kong 1
IL - Israele 1
NL - Olanda 1
NO - Norvegia 1
SA - Arabia Saudita 1
Totale 715
Città #
Ashburn 71
Fairfield 50
Santa Cruz 44
Woodbridge 28
Buffalo 26
Seattle 24
Houston 22
Dublin 21
Cambridge 15
Las Vegas 13
Boardman 12
Chicago 12
Wilmington 11
Columbus 7
Mountain View 7
Sofia 7
Ann Arbor 6
Bologna 6
Dallas 6
Dong Ket 6
Beijing 4
Bremen 4
Los Angeles 4
New York 4
Ottawa 4
Atlanta 3
Boston 3
Clearwater 3
Helsinki 3
Milan 3
Munich 3
Saint Petersburg 3
Tokyo 3
Waltham 3
Ankara 2
Basking Ridge 2
Bloomfield 2
Casablanca 2
Comano 2
Forlì 2
Frankfurt Am Main 2
Gangnam-gu 2
Herndon 2
New Kensington 2
Paris 2
Phoenix 2
Provo 2
Pune 2
Riva 2
Secaucus 2
Southend 2
Bagnacavallo 1
Bari 1
Bogotá 1
Brooklyn 1
Bryn Mawr 1
Carmel 1
Cedar Knolls 1
Como 1
Council Bluffs 1
Crema 1
Dearborn 1
Decatur 1
Dulles 1
Düsseldorf 1
Falls Church 1
Florence 1
Frankfurt am Main 1
Greenwood 1
Groningen 1
Göppingen 1
Hangzhou 1
Hong Kong 1
Ichibancho 1
Jacksonville 1
Jersey City 1
Las Palmas de Gran Canaria 1
Lebanon 1
Lossiemouth 1
Memphis 1
Minusio 1
Muizenberg 1
Musile di Piave 1
Nagasaki 1
New Delhi 1
Okazaki 1
Osaka 1
Oslo 1
Perth 1
Petah Tikva 1
Pieve di Cento 1
Pittsburgh 1
Portland 1
Providence 1
Qui Nhon 1
Ravenna 1
Reggio Emilia 1
Reston 1
Riyadh 1
Rozzano 1
Totale 524
Nome #
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia, file e1dcb332-f750-7715-e053-1705fe0a6cc9 108
The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report, file e1dcb330-5d38-7715-e053-1705fe0a6cc9 93
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file e1dcb338-c510-7715-e053-1705fe0a6cc9 84
Recurrent gastrointestinal hemorrhage in treatment with dasatinib in a patient showing SMAD4 mutation with acute lymphoblastic leukemia Philadelphia positive and juvenile polyposis hereditary hemorrhagic telangiectasia syndrome, file e1dcb332-7731-7715-e053-1705fe0a6cc9 83
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia, file e1dcb334-1481-7715-e053-1705fe0a6cc9 83
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia, file e1dcb335-710d-7715-e053-1705fe0a6cc9 78
A case report of acute myeloid leukemia and neurofibromatosis 1, file e1dcb335-41fc-7715-e053-1705fe0a6cc9 72
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia, file e1dcb335-375c-7715-e053-1705fe0a6cc9 66
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia, file 28c3b0be-1b08-4d0e-bd03-e2c9e8d48222 46
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia, file e1dcb337-384e-7715-e053-1705fe0a6cc9 14
Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment, file e1dcb330-8860-7715-e053-1705fe0a6cc9 5
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia, file 6b91808a-89ec-451f-bcac-4bd100943c74 3
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study, file b387d513-c986-410c-810c-62ca0510fad6 3
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients., file e1dcb32e-e3a9-7715-e053-1705fe0a6cc9 2
Posterior reversible encephalopathy syndrome in a B-cell acute lymphoblastic leukemia young adult patient treated with a pediatric-like chemotherapeutic schedule, file e1dcb330-8b09-7715-e053-1705fe0a6cc9 2
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia, file e1dcb335-56ce-7715-e053-1705fe0a6cc9 2
null, file e1dcb32d-4ae3-7715-e053-1705fe0a6cc9 1
Totale 745
Categoria #
all - tutte 2.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020113 0 0 0 5 8 15 16 14 16 10 15 14
2020/2021136 10 18 13 13 7 14 9 7 15 6 17 7
2021/2022142 9 5 5 11 19 1 2 11 4 1 57 17
2022/2023207 0 9 51 27 13 10 14 11 25 16 26 5
2023/2024144 4 4 6 14 16 29 28 12 20 5 6 0
Totale 745